Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022224

Expand all

TRILIPIX (CHOLINE FENOFIBRATE)
EQ 45MG FENOFIBRIC ACID Marketing Status: Prescription

Active Ingredient: CHOLINE FENOFIBRATE
Proprietary Name: TRILIPIX
Dosage Form; Route of Administration: CAPSULE, DELAYED RELEASE; ORAL
Strength: EQ 45MG FENOFIBRIC ACID
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N022224
Product Number: 001
Approval Date: Dec 15, 2008
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

TRILIPIX (CHOLINE FENOFIBRATE)
EQ 135MG FENOFIBRIC ACID Marketing Status: Prescription

Active Ingredient: CHOLINE FENOFIBRATE
Proprietary Name: TRILIPIX
Dosage Form; Route of Administration: CAPSULE, DELAYED RELEASE; ORAL
Strength: EQ 135MG FENOFIBRIC ACID
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022224
Product Number: 002
Approval Date: Dec 15, 2008
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English